View in EDS

Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.

Saved in:
Bibliographic Details
Title: Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
Authors: Berumen A; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Staron A; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Kalaitzidis G; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Siddiqi OK; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Gopal DM; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Ruberg FL; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA., Sanchorawala V; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
Source: Blood advances [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4612-4616.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41995749
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Berumen+A%22">Berumen A</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Staron+A%22">Staron A</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Kalaitzidis+G%22">Kalaitzidis G</searchLink>; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Siddiqi+OK%22">Siddiqi OK</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gopal+DM%22">Gopal DM</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ruberg+FL%22">Ruberg FL</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Cardiovascular Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Sanchorawala+V%22">Sanchorawala V</searchLink>; Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.; Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4612-4616.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41995749
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2026020177
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4612
    Titles:
      – TitleFull: Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Berumen A
      – PersonEntity:
          Name:
            NameFull: Staron A
      – PersonEntity:
          Name:
            NameFull: Kalaitzidis G
      – PersonEntity:
          Name:
            NameFull: Siddiqi OK
      – PersonEntity:
          Name:
            NameFull: Gopal DM
      – PersonEntity:
          Name:
            NameFull: Ruberg FL
      – PersonEntity:
          Name:
            NameFull: Sanchorawala V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 07
              Text: 2026 Jul 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1